Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Belgium / NCT02624362
Enrolling by invitation Not applicable

The Effect of Odors on Asthma Symptoms

NCT02624362 · tracked via the Priya Life Science Belgium tracker
Sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Not applicable
Started
2015-08
Last updated
2024-07-03

Condition(s) studied

Asthma

Investigational drug(s) / intervention(s)

Therapeutic SuggestionAsthmogenic SuggestionPhenylethyl Alcohol odor

Therapeutic Suggestion: suggestions about potential beneficial effects of the odor are given

Asthmogenic Suggestion: suggestions about potential negative effects of the odor are given

Phenylethyl Alcohol odor: Over the course of 15 minutes, participants, receive 15 short sniffs of Phenylethyl Alcohol odor

Study summary

An extended replication of Jaen \& Dalton (2014), the investigators aim to investigate the role of odors and associated trigger beliefs on symptom perception and airway inflammation in individuals with asthma

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * A physician diagnosis of asthma Exclusion Criteria: * FEV1 lower than 60% predicted * clinical condition other than asthma

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
UZ Leuven Leuven Belgium

More Universitaire Ziekenhuizen KU Leuven trials in Belgium

Side Effects of a Single Shot Intrathecal Morphine in Clinical Practice, a Retrospective Analysis Active, not recruiting
Glenohumeral Joint Contract Patterns in Osteoarthritic Glenoids Recruiting
Continuous Glucose Monitoring for Women With Gestational Diabetes Recruiting
Flemish Inguinal and Femoral Hernia Prospective Registry Recruiting
Ultrasound Features of Dupuytren's Disease Recruiting

Other trials for the same condition

The Potential Added Value of Impulse Oscillometry in Asthma Monitoring Recruiting
REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study Active, not recruiting
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma Active, not recruiting
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study Recruiting
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02624362 on ClinicalTrials.gov ↗ ← All trials in Belgium